Spine-Tech (SPYN) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Spine-Tech (SPYN)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: .com who wrote (73)	10/21/1996 12:02:00 PM
From: C Overton	of 242

I have appreciated the company information you and Bruce have shared on this thread. I suppose that you have seen the 3rdQ losses which were announced this am. and exceeded the company's estimates. On 3rd Q revenues of $1.5 million (down 27% from same Q last year), they lost .15/share. The CEO (I think) said that the FDA approval came later than they thought it might and that they "didn't meet their internal revenue expectations." I would guess that that means they were ramping up for the product rollout and got stymied by the FDA. I still think this "story stock" has got a long way to go, but appreciate your info as no one seems to follow this stock.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next